| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |